Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Good New/Bad news

Good New/Bad news

posted on Apr 02, 2007 01:07PM

Good. From Feb 7th (13GA filing) to Feb 28th (14A filing) it would appear that L&S share count was reduced by almost 6 mil shares, From 38.1 to 32.2 mil total including warrants. Bad. It would appear that we still have a significant warrant overhang of 23.8 mil warrants still to be converted. Please tell me I am wrong on that last point. Opty

Share
New Message
Please login to post a reply